CDC
ActiveSummary
The annual accounts of CDC for financial year 2025 show a net loss of 60% of the equity at the start of that year. The 2025 annual accounts show equity of €10,865 and a net result of -€16,260. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 24% of 9,496 sector peers (NACE 82, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
12-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Weakest financial yearnet -€16,260
Net result drops to -€16,260, the lowest in the series.
29-07
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
05-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 5 days late
2023
03-10
NBB filing
Annual accounts filed
financial year 2022 · full format · 64 days late
2022
04-08
NBB filing
Annual accounts filed
financial year 2021 · full format · 4 days late
2021
31-12
Financial
Back to profitnet €8,574
Net result €8,574 after one loss-making year.
26-11
NBB filing
Annual accounts filed
financial year 2020 · micro format · 118 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.